Huntington National Bank’s Roivant Sciences ROIV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$53.8K Buy
1,521
+1,360
+845% +$40.2K ﹤0.01% 1404
2026
Q1
$4.46K Hold
161
﹤0.01% 2094
2025
Q4
$3.49K Sell
161
-44
-21% -$868 ﹤0.01% 2084
2025
Q3
$3.1K Hold
205
﹤0.01% 2113
2025
Q2
$2.31K Sell
205
-139
-40% -$1.51K ﹤0.01% 2182
2025
Q1
$3.47K Buy
344
+296
+617% +$3.2K ﹤0.01% 2094
2024
Q4
$568 Buy
48
+6
+14% +$71 ﹤0.01% 2478
2024
Q3
$485 Buy
42
+1
+2% +$11 ﹤0.01% 2487
2024
Q2
$433 Buy
+41
New +$449 ﹤0.01% 2440

Other funds holding ROIV

Huntington National Bank's ROIV Position: Q2 2026 in Review

Huntington National Bank increased its Roivant Sciences (ROIV) stake by 845% in Q2 2026, buying an estimated $40.2K and bringing the position to 1,521 shares worth $53.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1404.

Huntington National Bank first reported a position in ROIV in Q2 2024 and has held it in 9 quarters since. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • Huntington National Bank held 1,521 shares of Roivant Sciences worth $53.8K as of Q2 2026.
  • Huntington National Bank bought 1,360 Roivant Sciences shares in Q2 2026, an estimated $40.2K.
  • Roivant Sciences made up ﹤0.01% of Huntington National Bank's portfolio in Q2 2026, its #1404 holding.
  • Huntington National Bank first reported a position in Roivant Sciences in Q2 2024 and has held it in 9 quarters since.
  • 498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Huntington National Bank's 13F filing for Q2 2026, filed 13 Aug 2026.